Glenmark Pharmaceuticals Limited

Výroční Annual Report FY2026 FY2026BSEPDF 13. srp 2026 před 3 měs. Výroční Annual Report FY2025 FY2025BSEPDF 29. srp 2025 před 1 r. Kvartální Please find attached herewith Unaudited Financial Results for the first quarter ended 30th June, 2025 FY2026 · Q1BSEPDF 14. srp 2025 před 1 r. Výroční Annual Report FY2024 FY2024BSEPDF 3. zář 2024 před 2 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting, approved the Unaudited Financial Results for the Third Quarter and Nine .... FY2024 · Q3BSEPDF 14. úno 2024 před 3 r. Kvartální Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board at its meeting held today has approved .... FY2024 · Q2BSEPDF 10. lis 2023 před 3 r. Výroční Annual Report FY2023 FY2023BSEPDF 4. zář 2023 před 3 r. Kvartální Unaudited Financial Results (Standalone and Consolidated) for the First Quarter ended 30th June, 2023 FY2024 · Q1BSEPDF 11. srp 2023 před 3 r. Výroční The Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on May 19, 2023, which commenced at 02.00 p.m. and concluded at 06.40 p.m., considered and approved the following: .... FY2023BSEPDF 19. kvě 2023 před 3 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting, approved the Unaudited Financial Results for the Third Quarter and .... FY2023 · Q3BSEPDF 10. úno 2023 před 4 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second Quarter and .... FY2023 · Q2BSEPDF 11. lis 2022 před 4 r. Výroční Annual Report FY2022 FY2022BSEPDF 27. srp 2022 před 4 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended .... FY2023 · Q1BSEPDF 10. srp 2022 před 4 r. Výroční Audited Financial Results for the year ended March 31, 2022. Pursuant to regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, find enclosed .... FY2022BSEPDF 27. kvě 2022 před 4 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the .... FY2022 · Q3BSEPDF 11. úno 2022 před 5 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second Quarter and Half .... FY2022 · Q2BSEPDF 12. lis 2021 před 5 r. Výroční Annual Report FY2021 FY2021BSEPDF 27. srp 2021 před 5 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended June 30, 2021. .... FY2022 · Q1BSEPDF 13. srp 2021 před 5 r. Výroční Audited Financial Results for the year ended March 31, 2021. Pursuant to regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, find enclosed .... FY2021BSEPDF 28. kvě 2021 před 5 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Third Quarter and Nine .... FY2021 · Q3BSEPDF 12. úno 2021 před 6 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second Quarter and Half .... FY2021 · Q2BSEPDF 6. lis 2020 před 6 r. Výroční Annual Report FY2020 FY2020BSEPDF 4. zář 2020 před 6 r. Kvartální Unaudited Financial Results (Standalone and Consolidated) for the First Quarter ended 30th June, 2020 FY2021 · Q1BSEPDF 14. srp 2020 před 6 r. Výroční Outcome of the Board Meeting - June 26, 2020 A.The Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on June 26, 2020, which commenced at 05.00 p.m. and concluded .... FY2020BSEPDF 26. čvn 2020 před 6 r. Kvartální The Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on February 14, 2020, which commenced at 02.00 p.m. and concluded at 6.40 p.m., considered and approved the following: .... FY2020 · Q3BSEPDF 14. úno 2020 před 7 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second Quarter and Half .... FY2020 · Q2BSEPDF 14. lis 2019 před 7 r. Výroční Annual Report FY2019 FY2019BSEPDF 3. zář 2019 před 7 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended June 30, 2019. .... FY2020 · Q1BSEPDF 13. srp 2019 před 7 r. Výroční A.The Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on May 29, 2019, which commenced at 02.30 p.m. and concluded at 09.05 p.m., considered and approved the following: .... FY2019BSEPDF 29. kvě 2019 před 7 r. Kvartální Sub: Outcome of the Board Meeting - February 14, 2019 Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR, 2015') .... FY2019 · Q3BSEPDF 14. úno 2019 před 8 r. Kvartální Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR, 2015') Pursuant to Regulations 30 and 33 of the .... FY2019 · Q2BSEPDF 13. lis 2018 před 8 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended June 30, 2018. .... FY2019 · Q1BSEPDF 10. srp 2018 před 8 r. Výroční Sub: Audited Financial Result for the year ended March 31, 2018 FY2018BSEPDF 29. kvě 2018 před 8 r. Kvartální Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Third Quarter and Nine .... FY2018 · Q3BSEPDF 8. úno 2018 před 9 r. Kvartální Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR, 2015') Pursuant to Regulations 30 and 33 of the .... FY2018 · Q2BSEPDF 2. lis 2017 před 9 r. Kvartální Sub: Outcome of the Board Meeting - July 27, 2017 Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .... FY2018 · Q1BSEPDF 27. čvc 2017 před 9 r. Výroční The Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on May 11, 2017, which commenced at 11.00 a.m. and concluded at 6.45 p.m., considered and approved the following: .... FY2017BSEPDF 11. kvě 2017 před 9 r. Kvartální Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2016: The Un-audited Standalone results for the Quarter ended December 31, 2016 .... FY2017 · Q3BSEPDF 2. úno 2017 před 10 r. Kvartální Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2016 The Unaudited Standalone results for the Quarter ended September 30, 2016 .... FY2017 · Q2BSEPDF 27. říj 2016 před 10 r. Kvartální Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended June 30, 2016: The Unaudited Standalone results for the Quarter ended June 30, 2016 The .... FY2017 · Q1BSEPDF 12. srp 2016 před 10 r. Výroční Glenmark Pharmaceuticals Ltd has announced the following results for the quarter & year ended March 31, 2016: The Audited Standalone results for the Quarter ended March 31, 2016 .... FY2016BSEPDF 12. kvě 2016 před 10 r. Kvartální Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2015: The Unaudited Standalone results for the Quarter ended December 31, 2015 (Indian GAAP) .... FY2016 · Q3BSEPDF 28. led 2016 před 11 r. Kvartální Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2015: The Unaudited Standalone results for the Quarter ended September 30, 2015 .... FY2016 · Q2BSEPDF 29. říj 2015 před 11 r. Kvartální Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended June 30, 2015: The Unaudited Standalone results for the Quarter ended June 30, 2015 "The .... FY2016 · Q1BSEPDF 30. čvc 2015 před 11 r. Výroční Glenmark Pharmaceuticals Ltd has announced the following results for the quarter & year ended March 31, 2015: The Standalone Results are as follows: The Audited results for .... FY2015BSEPDF 29. kvě 2015 před 11 r. Kvartální Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2014: The Unaudited Standalone results for the Quarter ended December 31, 2014 .... FY2015 · Q3BSEPDF 12. úno 2015 před 12 r.